
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & PodcastsFetching episode details...
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss how concerns about drug pricing have affected biopharma companies large and small, the latest threat to the biotech bubble, and Bristol-Myers Squibb's interesting televisual choices.
Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud is an episode from FierceBiotech Radio. Fierce editors discuss how concerns about drug pricing have affected biopharma companies large and small,...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Oct 1, 2015, 21:43 long, audio available.
Fierce editors discuss how concerns about drug pricing have affected biopharma companies large and small, the latest threat to the biotech bubble, and Bristol-Myers Squibb's interesting televisual choices.
You can listen to Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud online on Radio and Podcast. Open the player on this page to stream the available audio.
Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud is an episode from FierceBiotech Radio.
This episode is 21:43 long.
This episode was published on Oct 1, 2015.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud on this page when the episode audio is available from the podcast feed.
Valeant feels the Bern, biotech buckles on Wall Street, and Bristol-Myers turns to Family Feud is from FierceBiotech Radio.
Published Oct 1, 2015 and 21:43 long